ANX-042 Healthy Volunteer Dose Escalation Study

计划入组 30 人 · 首次发布于 2012 年 7 月 11 日

Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

计划入组 40 人 · 首次发布于 2017 年 1 月 12 日

ANX-188 Thorough QT/QTc Study in Healthy Volunteers

计划入组 72 人 · 首次发布于 2013 年 2 月 13 日

ANX-1502

ANX-776

ANX-105

Anx Robotica Corp

United States

XACT ROBOTICS LTD

Israel

NEXTSTEP ROBOTICS, INC.

United States

AnX Robotica Receives FDA 510(k) Clearance for MotiliCap and MotiliScan GI Motility Monitoring System

Huntington's Disease Pipeline Shows Robust Growth with 20+ Companies Developing Novel Therapies

Huntington's Disease Market Poised for 14% CAGR Growth Through 2036 as Disease-Modifying Therapies Advance